Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
NAT2 and leukemia are reported together in 2 articles.
Gene
NAT2
- HGNC
- HGNC:7646
14articles
14mentions
4variants with confirmed gene link
Most co-reported phenotypes (articles)
tuberculosis 3colorectal cancer 2diabetes mellitus 2leukemia 2rheumatoid arthritis 2cystic fibrosis 1hepatitis C 1thyroid cancer 1
Reported variants (articles · ClinVar status)
Phenotype
Leukemia
652articles
652mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
2 records shown · first 60A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia.
PMID 37715989 | DOI 10.18388/abp.2020_6235 · Acta biochimica Polonica · 2023 · 7 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | NAT2 | “A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia.” | 0.98 | hgnc_dict_v1 |
| phenotype | leukemia | “A case-control study in NAT2 gene polymorphism studies in patients diagnosed with acute myeloid leukemia.” | 0.98 | phenotype_alias_lexicon_v2 |
| population | Saudi Arabia | “AIM: In this case-control study, C481T (rs1799929) and G857A (rs1799931) polymorphism studies were investigated in diagnosed AML patients in the Saudi population. METHODS: This case-control study included 100 AML patients and 100 control subjects recruited in Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |
| variant | rs1799929 | “AIM: In this case-control study, C481T (rs1799929) and G857A (rs1799931) polymorphism studies were investigated in diagnosed AML patients in the Saudi population.” | 0.90 | hgvs_regex_v1 |
Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.
PMID 33369472 | PMCID PMC8046315 | DOI 10.31557/APJCP.2020.21.12.3711 · Asian Pacific journal of cancer prevention : APJCP · 2020 · 8 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | NAT2 | “OBJECTIVES: The N-Acetyltransferase 2 (NAT2) gene encodes a key enzyme involved in xenobiotic metabolism, which contributes to the detoxification of numerous cancer therapy-induced products.” | 0.98 | hgnc_dict_v1 |
| phenotype | leukemia | “Evaluation of Genetic Polymorphisms of N-acetyltransferase 2 and Relation with Chronic Myeloid Leukemia.” | 0.98 | phenotype_alias_lexicon_v2 |
| variant | C481T | “The aim of this study was to determine whether its polymorphisms (C481T, G590A, 803A>G and 857G>A) have a role in chronic myeloid leukemia susceptibility (CML) in Sudanese population.” | 0.82 | literature_variant_regex_v2 |
| variant | G590A | “The aim of this study was to determine whether its polymorphisms (C481T, G590A, 803A>G and 857G>A) have a role in chronic myeloid leukemia susceptibility (CML) in Sudanese population.” | 0.82 | literature_variant_regex_v2 |